FILTER

Refine your search with the following facets to narrow down your results.

8 Current news of CHDI

Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease

31-Aug-2018 - Evotec AG announced that CHDI Foundation, Inc. has extended its collaboration with Evotec through to 2023. Over this period, CHDI may fund up to 75 full-time scientists at Evotec. The collaboration was initiated in 2006 and has grown considerably over this period to fully utilise Evotec’s ...

Evotec Huntington's disease

Evotec and CHDI Foundation expand ongoing collaboration to fight Huntington's disease

03-Sep-2015 - Evotec AG announced that CHDI Foundation, Inc. has extended and expanded its collaboration with Evotec through to August 2018. Over this period CHDI will fund 55 full-time scientists at Evotec. The collaboration-which aims to find new treatments for Huntington's disease, an inherited ...

Evotec Huntington's disease

Evotec and CHDI Foundation extend ongoing collaboration to fight Huntington's disease

12-Sep-2014 - Evotec AG announced that CHDI Foundation, Inc. has extended and restated its collaboration with Evotec through 2017. The collaboration-which aims to find new treatments for Huntington's disease, an inherited neurodegenerative disorder-means that CHDI will fund up to 52 full-time scientistsat ...

drug discovery Evotec Huntington's disease

Evotec extends ongoing collaboration with CHDI Foundation

30-Oct-2012 - Evotec AG announced that CHDI Foundation, Inc. (CHDI), a privately-funded not-for-profit research organisation dedicated to developing therapies for Huntington's disease (HD), has extended its collaboration with Evotec until the end of 2015. This contract extension could be worth up to USD 41 ...

Evotec Huntington's disease

Proteros and CHDI Foundation, Inc. establish discovery services collaboration to address Huntington’s disease

21-Mar-2011 - Proteros Biostructures GmbH (Proteros) announced that it has entered into a service agreement with CHDI Foundation, Inc. (CHDI), under which Proteros will provide structure-based drug discovery services to CHDI. Proteros will apply its integrated discovery platform including proprietary X-ray ...

drug discovery x-ray crystallography

Galapagos and CHDI Foundation, Inc. enter new five-year collaboration for Huntington's disease therapeutics

30-Apr-2010 - Galapagos NV and CHDI Foundation, Inc. announced today a new five-year collaboration focused on discovering novel drugs for Huntington's disease. Galapagos' service division BioFocus will perform the research and is eligible to receive US$41 million (€31 million) in research fees during the ...

biology chemistry computational chemistry +3

Evotec and CHDI Foundation, Inc. Extend Collaboration to Fight Huntington’s Disease

18-Jan-2010 - Evotec AG announced the extension of its collaboration with CHDI Foundation, Inc. (CHDI) through to the end of 2012. The collaboration, which is aimed at finding new treatments for Huntington’s disease and represents one of the largest joint innovation drug discovery CNS alliances within Evotec, ...

biology chemistry CNS drugs +6

Galapagos and CHDI enter new collaboration agreements

30-Oct-2008 - Galapagos NV and CHDI Foundation, Inc., a non-profit organization pursuing treatments for Huntington's disease (HD), announced new collaboration agreements focused on developing novel assays for drug discovery and evaluating known compounds as potentially new therapeutic approaches for HD. ...

bases BioFocus DPI enzymes +2